Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...

It delivers DNA instructions to make the custom proteins inside brain cells. Elderly mice with tau protein aggregates were injected with a single dose of the gene therapy vector containing either the ...

It delivers DNA instructions to make the custom proteins inside brain cells. Elderly mice with tau protein aggregates were injected with a single dose of the gene therapy vector containing either the ...

It delivers DNA instructions to make the custom proteins inside brain cells. Elderly mice with tau protein aggregates were injected with a single dose of the gene therapy vector containing either ...

Larry and Joan Arnold have donated $1 million to Morningside University for an entrepreneurship and economic development center in the new school of business.

Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and repurposing existing drugs to address unmet medical needs.

The benefits do not stop there. Recent studies suggest GLP-1 drugs may also reduce the risk of heart disease, kidney disease and stroke, and even possibly protect the brain from AD by reducing ...

Annovis is at the forefront, testing buntanetap in pivotal clinical trials as a therapy for Alzheimer's and Parkinson's diseases (PD). Company has filed three new patents protecting combinations of ...